Tvardi Therapeutics, Inc. (TVRD)
Tvardi Therapeutics, Inc. (TVRD) Insider Trading
Directors, officers and holders of more than 10% of TVRD report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 50 transactions on file: 0 with code P, 0 with code S and 50 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | WYZGA MICHAEL S | Director | A Award | 6,000 | Not measured | Not measured |
| Jun 9, 2026 | Shiff Susan Ph.D. | Director | A Award | 6,000 | Not measured | Not measured |
| Jun 9, 2026 | Smith Cynthia | Director | A Award | 6,000 | Not measured | Not measured |
| Jun 9, 2026 | HALL WALLACE L JR | Director | A Award | 6,000 | Not measured | Not measured |
| Jun 9, 2026 | Shah Sujal | Director | A Award | 6,000 | Not measured | Not measured |
| Jan 29, 2026 | O'Brien Stephen Paul | Principal Accounting Officer | A Award | 15,000 | Not measured | Not measured |
| Jan 29, 2026 | Alibhai Imran Nizamudin | Chief Executive Officer | A Award | 115,000 | Not measured | Not measured |
| Jan 29, 2026 | Kauh John Saewook M.D. | Chief Medical Officer | A Award | 45,000 | Not measured | Not measured |
| Jan 29, 2026 | Conn Avi Daniel | Chief Financial Officer | A Award | 45,000 | Not measured | Not measured |
| Dec 16, 2025 | Conn Avi Daniel | Chief Financial Officer | A Award | 17,500 | Not measured | Not measured |
| Dec 16, 2025 | Alibhai Imran Nizamudin | Chief Executive Officer | A Award | 47,500 | Not measured | Not measured |
| Dec 16, 2025 | O'Brien Stephen Paul | Principal Accounting Officer | A Award | 4,000 | Not measured | Not measured |
| Dec 16, 2025 | Kauh John Saewook M.D. | Chief Medical Officer | A Award | 17,500 | Not measured | Not measured |
| Jul 7, 2025 | Tweardy Samuel David | 10% Owner | J Other | 315,658 | Not measured | Not measured |
| Jul 7, 2025 | Tweardy Samuel David | 10% Owner | J Other | 315,658 | Not measured | Not measured |
| Apr 17, 2025 | Kauh John Saewook M.D. | Chief Medical Officer | A Award | 36,210 | Not measured | Not measured |
| Apr 17, 2025 | Larson Jeffrey Leroy | SVP, Research & Development | A Award | 10,820 | Not measured | Not measured |
| Apr 17, 2025 | O'Brien Stephen Paul | Principal Accounting Officer | A Award | 7,213 | Not measured | Not measured |
| Apr 17, 2025 | Chen Yixin | VP, Chem, Mfg and Ctrls | A Award | 7,213 | Not measured | Not measured |
| Apr 17, 2025 | Conn Avi Daniel | Chief Financial Officer | A Award | 43,547 | Not measured | Not measured |
| Apr 17, 2025 | WYZGA MICHAEL S | Director | A Award | 12,000 | Not measured | Not measured |
| Apr 17, 2025 | Smith Cynthia | Director | A Award | 12,000 | Not measured | Not measured |
| Apr 17, 2025 | Shah Sujal | Director | A Award | 12,000 | Not measured | Not measured |
| Apr 17, 2025 | Alibhai Imran Nizamudin | Chief Executive Officer | A Award | 182,320 | Not measured | Not measured |
| Apr 17, 2025 | Shiff Susan Ph.D. | Director | A Award | 12,000 | Not measured | Not measured |
| Apr 17, 2025 | HALL WALLACE L JR | Director | A Award | 12,000 | Not measured | Not measured |
| Apr 17, 2025 | Wirk Shaheen | Director | A Award | 12,000 | Not measured | Not measured |
| Apr 15, 2025 | Conn Avi Daniel | Chief Financial Officer | A Award | 89,053 | Not measured | Not measured |
| Apr 15, 2025 | Alibhai Imran Nizamudin | Chief Executive Officer | A Award | 207,881 | Not measured | Not measured |
| Apr 15, 2025 | Alibhai Imran Nizamudin | Chief Executive Officer | A Award | 2,011 | Not measured | Not measured |
| Apr 15, 2025 | Alibhai Imran Nizamudin | Chief Executive Officer | A Award | 160,940 | Not measured | Not measured |
| Apr 15, 2025 | Wirk Shaheen | Director | A Award | 1,397 | Not measured | Not measured |
| Apr 15, 2025 | HALL WALLACE L JR | Director | J Other | 67,348 | Not measured | Not measured |
| Apr 15, 2025 | HALL WALLACE L JR | Director | J Other | 14,904 | Not measured | Not measured |
| Apr 15, 2025 | Wirk Shaheen | Director | A Award | 87,721 | Not measured | Not measured |
| Apr 15, 2025 | Wirk Shaheen | Director | A Award | 58,677 | Not measured | Not measured |
| Apr 15, 2025 | HALL WALLACE L JR | Director | A Award | 67,348 | Not measured | Not measured |
| Apr 15, 2025 | HALL WALLACE L JR | Director | A Award | 14,904 | Not measured | Not measured |
| Apr 15, 2025 | Wirk Shaheen | Director | J Other | 87,721 | Not measured | Not measured |
| Apr 15, 2025 | WYZGA MICHAEL S | Director | A Award | 18,441 | Not measured | Not measured |
| Apr 15, 2025 | Shah Sujal | Director | A Award | 10,394 | Not measured | Not measured |
| Apr 15, 2025 | Shah Sujal | Director | A Award | 8,047 | Not measured | Not measured |
| Apr 15, 2025 | O'Brien Stephen Paul | Principal Accounting Officer | A Award | 11,399 | Not measured | Not measured |
| Apr 15, 2025 | O'Brien Stephen Paul | Principal Accounting Officer | A Award | 3,352 | Not measured | Not measured |
| Apr 15, 2025 | Wirk Shaheen | Director | J Other | 58,677 | Not measured | Not measured |
| Apr 15, 2025 | Kauh John Saewook M.D. | Chief Medical Officer | A Award | 74,049 | Not measured | Not measured |
| Apr 15, 2025 | Chen Yixin | VP, Chem, Mfg and Ctrls | A Award | 14,752 | Not measured | Not measured |
| Apr 15, 2025 | Wirk Shaheen | Director | A Award | 2,011 | Not measured | Not measured |
| Apr 15, 2025 | Larson Jeffrey Leroy | SVP, Research & Development | A Award | 16,764 | Not measured | Not measured |
| Apr 15, 2025 | Larson Jeffrey Leroy | SVP, Research & Development | A Award | 5,364 | Not measured | Not measured |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.